Eastwood Bio-Medical Canada (TSXV:EBM) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:EBM Eastwood Bio-Medical Canada Inc TSXV:EBM
25 GF Score
Price C$0.99
GF Value C$0.53
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Eastwood Bio-Medical Canada Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TSXV:EBM vs VRTX, REGN, RVMD: Short Percentage of Float Comparison

For the Biotechnology subindustry, Eastwood Bio-Medical Canada's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eastwood Bio-Medical Canada Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eastwood Bio-Medical Canada's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Eastwood Bio-Medical Canada's Short Percentage of Float falls into.


TSXV:EBM
25GF Score
Eastwood Bio-Medical Canada Inc TSXV:EBM
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eastwood Bio-Medical Canada (TSXV:EBM) Overvalued in 2026?

Based on GuruFocus' analysis, Eastwood Bio-Medical Canada stock appears to be overvalued. The current stock price of C$0.99 is trading 86.8% above its estimated GF Value™ of C$0.53. GuruFocus considers Eastwood Bio-Medical Canada to be Significantly Overvalued.

Key valuation signals for TSXV:EBM:

  • Short Percentage of Float:
  • GF Value™: C$0.53 vs. price of C$0.99 (86.8% above fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the TSXV:EBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eastwood Bio-Medical Canada Business Description

Address 4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6
Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.
25GF Score

Get the complete analysis for TSXV:EBM

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.99
Price
C$0.53
GF Value